on 30 Dec 2022
Last Applicant/ Owned by
The Oxford Science Park Oxford OX4 4GA
GB
Serial Number
79168971 filed on 17th Dec 2014
Registration Number
4975416 registered on 14th Jun 2016
Correspondent Address
Bryce J. Maynard
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Scientific research for medical purposes in the fields of allergies, drug dependency, substance addiction, autoimmune disease, poisoning, overdose, envenomation transplant rejection, immunodeficiency disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculRead More
Scientific research for medical purposes in the fields of allergies, drug dependency, substance addiction, autoimmune disease, poisoning, overdose, envenomation transplant rejection, immunodeficiency disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, gynaecological, oncological, hepatological, ocular, haemostasis, obstetric, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, renal system, urinary tract, otolaryngology, psychiatric, fertility and immune system related diseases and disorders; medical and pharmacological research services in the fields of allergies, drug dependency, substance addiction, autoimmune disease, poisoning, overdose, envenomation, transplant rejection, immunodeficiency disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, gynaecological, oncological, hepatological, ocular, haemostasis, obstetric, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, renal system, urinary tract, otolaryngology, psychiatric, fertility and immune system related diseases and disorders; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the fields of pharmaceutical and clinical trials; conducting clinical trials for others; information, advisory and consultancy services relating to the aforesaid
Pharmaceutical and veterinary preparations for the testing, diagnosis, prevention or treatment of drug dependency, substance addiction, poisoning, overdose, envenomation, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, gynaecological, oncological, hepatological, ocular, haemostasis, obstetric, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, renal system, urinary tract, otolaryngology, psychiatric, fertility and immune system related diseases and disorders
No 79168971
No Service Mark
No
No
No
No
No
Yes
Yes
No
No
26.07.15 -
Four or more diamonds
26.07.21 -
Diamonds that are completely or partially shaded
The mark consists of a miscellaneous design comprising seven diamond shapes with the colour dark purple applied to four of the diamond shapes and the colour light purple applied to three of the diamond shapes.
| Status Date | Action Taken |
|---|---|
| 09th Oct 2023 | TOTAL INVALIDATION PROCESSED BY THE IB |
| 16th Sep 2023 | INVALIDATION PROCESSED |
| 16th Sep 2023 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 30th Aug 2023 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 30th Dec 2022 | CANCELLED SECTION 71 |
| 04th Dec 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| 14th Jun 2021 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 25th Oct 2019 | NEW REPRESENTATIVE AT IB RECEIVED |
| 13th Oct 2016 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 19th Sep 2016 | FINAL DISPOSITION PROCESSED |
